# GrowGeneration Corp.: financial statements, quarterly

GRWG · Nasdaq · CIK 1604868 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grwg.md) · [Financials](/companies/grwg/financials.md) · [Filings](/companies/grwg/filings.md) · [Insiders](/companies/grwg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grwg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.7](/filings/0001628280-24-047297.md) | [49.5 d](/filings/0001604868-26-000004.md) | [47.9](/filings/0001604868-25-000016.md) | [53.5](/filings/0001604868-25-000027.md) | [50.0](/filings/0001604868-25-000032.md) | [37.4 d](/filings/0001604868-26-000004.md) | [35.7](/filings/0001604868-26-000012.md) | [41.0](/filings/0001604868-26-000020.md) | [47.3](/filings/0001604868-25-000032.md) | [37.8 d](/filings/0001604868-26-000004.md) | [38.4](/filings/0001604868-26-000012.md) | [43.2](/filings/0001604868-26-000020.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [16.2](/filings/0001628280-24-047297.md) | [11.6 d](/filings/0001604868-26-000004.md) | [12.4](/filings/0001604868-25-000016.md) | [14.4](/filings/0001604868-25-000027.md) | [10.8](/filings/0001604868-25-000032.md) | [6.1 d](/filings/0001604868-26-000004.md) | [9.7](/filings/0001604868-26-000012.md) | [11.6](/filings/0001604868-26-000020.md) | [12.9](/filings/0001604868-25-000032.md) | [9.1 d](/filings/0001604868-26-000004.md) | [9.7](/filings/0001604868-26-000012.md) | [12.3](/filings/0001604868-26-000020.md) |
| Selling, general and administrative | $m | [7.6](/filings/0001628280-24-047297.md) | [7.9 d](/filings/0001604868-26-000004.md) | [7.9](/filings/0001604868-25-000016.md) | [7.1](/filings/0001604868-25-000027.md) | [7.4](/filings/0001604868-25-000032.md) | [6.8 d](/filings/0001604868-26-000004.md) | [7.1](/filings/0001604868-26-000012.md) | [6.2](/filings/0001604868-26-000020.md) | [5.7](/filings/0001604868-25-000032.md) | [7.3 d](/filings/0001604868-26-000004.md) | [6.9](/filings/0001604868-26-000012.md) | [6.5](/filings/0001604868-26-000020.md) |
| Operating income | $m | [(8.0)](/filings/0001628280-24-047297.md) | [(28.1) d](/filings/0001604868-26-000004.md) | [(9.4)](/filings/0001604868-25-000016.md) | [(6.5)](/filings/0001604868-25-000027.md) | [(12.1)](/filings/0001604868-25-000032.md) | [(23.9) d](/filings/0001604868-26-000004.md) | [(9.9)](/filings/0001604868-26-000012.md) | [(5.3)](/filings/0001604868-26-000020.md) | [(2.8)](/filings/0001604868-25-000032.md) | [(7.6) d](/filings/0001604868-26-000004.md) | [(5.3)](/filings/0001604868-26-000012.md) | [(2.3)](/filings/0001604868-26-000020.md) |
| Interest expense | $m | [0.0](/filings/0001628280-24-047297.md) | [0.1 d](/filings/0001604868-26-000004.md) | [0.1](/filings/0001604868-25-000016.md) | [0.0](/filings/0001604868-25-000027.md) | [0.0](/filings/0001604868-25-000032.md) | [0.0 d](/filings/0001604868-26-000004.md) | [0.0](/filings/0001604868-25-000016.md) | [0.0](/filings/0001604868-25-000027.md) | [0.0](/filings/0001604868-25-000032.md) | [0.0 d](/filings/0001604868-26-000004.md) | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001628280-24-047297.md) | [(0.1) d](/filings/0001604868-26-000004.md) | [(0.0)](/filings/0001604868-25-000016.md) | [0.1](/filings/0001604868-25-000027.md) | [(0.0)](/filings/0001604868-25-000032.md) | [0.1 d](/filings/0001604868-26-000004.md) | [0.0](/filings/0001604868-26-000012.md) | [0.0](/filings/0001604868-26-000020.md) | [0.0](/filings/0001604868-25-000032.md) | [0.2 d](/filings/0001604868-26-000004.md) | [(0.0)](/filings/0001604868-26-000012.md) | [0.0](/filings/0001604868-26-000020.md) |
| Net income | $m | [(7.3)](/filings/0001628280-24-047297.md) | [(27.3) d](/filings/0001604868-26-000004.md) | [(8.8)](/filings/0001604868-25-000032.md) | [(5.9)](/filings/0001604868-25-000032.md) | [(11.4)](/filings/0001604868-25-000032.md) | [(23.3) d](/filings/0001604868-26-000004.md) | [(9.4)](/filings/0001604868-26-000020.md) | [(4.8)](/filings/0001604868-26-000020.md) | [(2.4)](/filings/0001604868-25-000032.md) | [(7.4) d](/filings/0001604868-26-000004.md) | [(4.9)](/filings/0001604868-26-000020.md) | [(2.0)](/filings/0001604868-26-000020.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001628280-24-047297.md) | not reported | [(0.14)](/filings/0001604868-25-000016.md) | [(0.10)](/filings/0001604868-25-000027.md) | [(0.19)](/filings/0001604868-25-000032.md) | not reported | [(0.16)](/filings/0001604868-26-000012.md) | [(0.08)](/filings/0001604868-26-000020.md) | [(0.04)](/filings/0001604868-25-000032.md) | not reported | [(0.08)](/filings/0001604868-26-000012.md) | [(0.03)](/filings/0001604868-26-000020.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0001628280-24-047297.md) | not reported | [(0.14)](/filings/0001604868-25-000016.md) | [(0.10)](/filings/0001604868-25-000027.md) | [(0.19)](/filings/0001604868-25-000032.md) | not reported | [(0.16)](/filings/0001604868-26-000012.md) | [(0.08)](/filings/0001604868-26-000020.md) | [(0.04)](/filings/0001604868-25-000032.md) | not reported | [(0.08)](/filings/0001604868-26-000012.md) | [(0.03)](/filings/0001604868-26-000020.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.4](/filings/0001628280-23-037938.md) | [29.8](/filings/0001628280-25-012661.md) | [31.1](/filings/0001628280-24-021773.md) | [27.6](/filings/0001628280-24-036179.md) | [27.4](/filings/0001628280-24-047297.md) | [27.5](/filings/0001604868-26-000004.md) | [32.7](/filings/0001604868-25-000016.md) | [23.3](/filings/0001604868-25-000027.md) | [27.4](/filings/0001604868-25-000032.md) | [30.4](/filings/0001604868-26-000020.md) | [21.7](/filings/0001604868-26-000012.md) | [23.5](/filings/0001604868-26-000020.md) |
| Current assets | $m | [164](/filings/0001628280-23-037938.md) | [147](/filings/0001628280-25-012661.md) | [142](/filings/0001628280-24-021773.md) | [135](/filings/0001628280-24-036179.md) | [123](/filings/0001628280-24-047297.md) | [113](/filings/0001604868-26-000004.md) | [109](/filings/0001604868-25-000016.md) | [109](/filings/0001604868-25-000027.md) | [112](/filings/0001604868-25-000032.md) | [104](/filings/0001604868-26-000020.md) | [99.7](/filings/0001604868-26-000012.md) | [99.6](/filings/0001604868-26-000020.md) |
| Total assets | $m | [277](/filings/0001628280-23-037938.md) | [239](/filings/0001628280-25-012661.md) | [230](/filings/0001628280-24-021773.md) | [219](/filings/0001628280-24-036179.md) | [200](/filings/0001628280-24-047297.md) | [174](/filings/0001604868-26-000004.md) | [164](/filings/0001604868-25-000016.md) | [161](/filings/0001604868-25-000027.md) | [160](/filings/0001604868-25-000032.md) | [147](/filings/0001604868-26-000020.md) | [140](/filings/0001604868-26-000012.md) | [137](/filings/0001604868-26-000020.md) |
| Current liabilities | $m | [40.5](/filings/0001628280-23-037938.md) | [30.9](/filings/0001628280-25-012661.md) | [29.3](/filings/0001628280-24-021773.md) | [29.2](/filings/0001628280-24-036179.md) | [24.5](/filings/0001628280-24-047297.md) | [24.3](/filings/0001604868-26-000004.md) | [24.9](/filings/0001604868-25-000016.md) | [27.3](/filings/0001604868-25-000027.md) | [29.3](/filings/0001604868-25-000032.md) | [26.0](/filings/0001604868-26-000020.md) | [24.6](/filings/0001604868-26-000012.md) | [25.6](/filings/0001604868-26-000020.md) |
| Total liabilities | $m | [77.2](/filings/0001628280-23-037938.md) | [65.7](/filings/0001628280-25-012661.md) | [65.1](/filings/0001628280-24-021773.md) | [63.4](/filings/0001628280-24-036179.md) | [56.5](/filings/0001628280-24-047297.md) | [54.3](/filings/0001604868-26-000004.md) | [53.1](/filings/0001604868-25-000016.md) | [53.9](/filings/0001604868-25-000027.md) | [54.9](/filings/0001604868-25-000032.md) | [49.5](/filings/0001604868-26-000020.md) | [46.7](/filings/0001604868-26-000012.md) | [46.6](/filings/0001604868-26-000020.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001628280-23-037938.md) | [0.0](/filings/0001628280-24-010996.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [200](/filings/0001628280-24-047297.md) | [173](/filings/0001604868-26-000004.md) | [165](/filings/0001604868-25-000032.md) | [156](/filings/0001604868-25-000032.md) | [143](/filings/0001604868-25-000032.md) | [120](/filings/0001604868-26-000020.md) | [111](/filings/0001604868-26-000020.md) | [107](/filings/0001604868-26-000020.md) | [105](/filings/0001604868-25-000032.md) | [97.5](/filings/0001604868-26-000020.md) | [92.8](/filings/0001604868-26-000020.md) | [90.0](/filings/0001604868-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(4,602) d](/filings/0001628280-24-047297.md) | [(1,356) d](/filings/0001604868-26-000004.md) | [(3,646)](/filings/0001604868-25-000016.md) | [(398) d](/filings/0001604868-25-000027.md) | [1,171 d](/filings/0001604868-25-000032.md) | [1,074 d](/filings/0001604868-26-000004.md) | [(3,829)](/filings/0001604868-26-000012.md) | [(2,921) d](/filings/0001604868-26-000020.md) | [(499) d](/filings/0001604868-25-000032.md) | [(2,198) d](/filings/0001604868-26-000004.md) | [(5,048)](/filings/0001604868-26-000012.md) | [941 d](/filings/0001604868-26-000020.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [0.0 d](/filings/0001628280-24-047297.md) | [0.0 d](/filings/0001604868-26-000004.md) | not reported | not reported | [1,846 d](/filings/0001604868-25-000032.md) | [1.0 d](/filings/0001604868-26-000004.md) | not reported | not reported | [0.0 d](/filings/0001604868-25-000032.md) | [0.0 d](/filings/0001604868-26-000004.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.9](/filings/0001628280-23-037938.md) | [61.0](/filings/0001628280-24-021773.md) | [61.1](/filings/0001628280-24-036179.md) | [61.3](/filings/0001628280-24-047297.md) | [61.5](/filings/0001604868-25-000016.md) | [60.7](/filings/0001604868-25-000027.md) | [59.3](/filings/0001604868-25-000032.md) | [59.4](/filings/0001604868-26-000012.md) | [59.6](/filings/0001604868-26-000020.md) | [59.8](/filings/0001604868-25-000032.md) | [60.1](/filings/0001604868-26-000012.md) | [59.8](/filings/0001604868-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,920,449 at 2026-08-05, from the cover of the [10-Q filed 2026-08-11](/filings/0001604868-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.